retatrutide drops More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase Retatrutide: A Triple Agonist Shaping

Smaller meals often mean smaller vegetable portions, and fibre intake can drop accordingly, which can also worsen the constipation that's already a common side effect of GLP-1 medications

When the body senses significant caloric deficit, it reallocates resources away from non-essential functions

However, most patients do not experience serious symptoms, with one study showing only 4% of patients experienced intense diarrhea

See our Refund Policy for details on cancellations and refunds.

Protein Protein has long been associated with feeling fuller after meals, and GLP-1 helps explain why

Choosing the right next-gen weight loss medication is a decision that requires expert guidance, integrating the latest clinical data with your unique health history, cardiovascular profile, and longevity goals